Kris MG - Search Results

1

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers.

Dogan S, Shen R, Ang DC, Johnson ML, D'Angelo SP, Paik PK, Brzostowski EB, Riely GJ, Kris MG, Zakowski MF, Ladanyi M. Dogan S, et al. Among authors: kris mg. Clin Cancer Res. 2012 Nov 15;18(22):6169-77. doi: 10.1158/1078-0432.CCR-11-3265. Epub 2012 Sep 26. Clin Cancer Res. 2012. PMID: 23014527 Free PMC article.

2

Metabolic phenotypes of retinoic acid and the risk of lung cancer.

Rigas JR, Miller VA, Zhang ZF, Klimstra DS, Tong WP, Kris MG, Warrell RP Jr. Rigas JR, et al. Among authors: kris mg. Cancer Res. 1996 Jun 15;56(12):2692-6. Cancer Res. 1996. PMID: 8665495

3

Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.

Grant SC, Kris MG, Houghton AN, Chapman PB. Grant SC, et al. Among authors: kris mg. Clin Cancer Res. 1999 Jun;5(6):1319-23. Clin Cancer Res. 1999. PMID: 10389914 Clinical Trial.

4

Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.

Dickler MN, Ragupathi G, Liu NX, Musselli C, Martino DJ, Miller VA, Kris MG, Brezicka FT, Livingston PO, Grant SC. Dickler MN, et al. Among authors: kris mg. Clin Cancer Res. 1999 Oct;5(10):2773-9. Clin Cancer Res. 1999. PMID: 10537341

5

The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.

Parekh K, Rusch V, Kris M. Parekh K, et al. Cancer. 1999 Nov 1;86(9):1720-3. Cancer. 1999. PMID: 10547544

6

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.

Krug LM, Ng KK, Kris MG, Miller VA, Tong W, Heelan RT, Leon L, Leung D, Kelly J, Grant SC, Sirotnak FM. Krug LM, et al. Among authors: kris mg. Clin Cancer Res. 2000 Sep;6(9):3493-8. Clin Cancer Res. 2000. PMID: 10999734 Clinical Trial.

7

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.

Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG. Sirotnak FM, et al. Among authors: kris mg. Clin Cancer Res. 2000 Dec;6(12):4885-92. Clin Cancer Res. 2000. PMID: 11156248

8

Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.

Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski G, Pisters KM, Heelan RT, Sirotnak FM. Laurie SA, et al. Among authors: kris mg. Clin Cancer Res. 2001 Mar;7(3):501-9. Clin Cancer Res. 2001. PMID: 11297240 Clinical Trial.

9

The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.

Laurie SA, Kris MG, Portlock CS, Rosenzweig KE, Miller VA, Krug LM, Rusch VW. Laurie SA, et al. Among authors: kris mg. Cancer. 2002 Jul 1;95(1):119-26. doi: 10.1002/cncr.10628. Cancer. 2002. PMID: 12115325 Free article.

10

Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma.

Ebright MI, Zakowski MF, Martin J, Venkatraman ES, Miller VA, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW. Ebright MI, et al. Among authors: kris mg. Ann Thorac Surg. 2002 Nov;74(5):1640-6; discussion 1646-7. doi: 10.1016/s0003-4975(02)03897-3. Ann Thorac Surg. 2002. PMID: 12440623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page